- Home
- NTRB vs VATE Comparison
NTRB vs VATE Comparison
Compare NTRB & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- VATE
- Stock Information
- Founded
- NTRB 2016
- VATE 1994
- Country
- NTRB United States
- VATE United States
- Employees
- NTRB N/A
- VATE 4024
- Industry
- NTRB Industrial Specialties
- VATE Metal Fabrications
- Sector
- NTRB Health Care
- VATE Industrials
- Exchange
- NTRB Nasdaq
- VATE Nasdaq
- Market Cap
- NTRB 77.9M
- VATE 82.6M
- IPO Year
- NTRB N/A
- VATE 1996
- Fundamental
- Price
- NTRB $6.17
- VATE $6.10
- Analyst Decision
- NTRB
- VATE
- Analyst Count
- NTRB 0
- VATE 0
- Target Price
- NTRB N/A
- VATE N/A
- AVG Volume (30 Days)
- NTRB 28.2K
- VATE 50.3K
- Earning Date
- NTRB 12-11-2024
- VATE 11-06-2024
- Dividend Yield
- NTRB N/A
- VATE N/A
- EPS Growth
- NTRB N/A
- VATE N/A
- EPS
- NTRB N/A
- VATE N/A
- Revenue
- NTRB $1,803,816.00
- VATE $1,364,600,000.00
- Revenue This Year
- NTRB N/A
- VATE N/A
- Revenue Next Year
- NTRB N/A
- VATE N/A
- P/E Ratio
- NTRB N/A
- VATE N/A
- Revenue Growth
- NTRB N/A
- VATE N/A
- 52 Week Low
- NTRB $1.93
- VATE $3.25
- 52 Week High
- NTRB $9.60
- VATE $14.60
- Technical
- Relative Strength Index (RSI)
- NTRB 50.57
- VATE 71.67
- Support Level
- NTRB $5.24
- VATE $6.18
- Resistance Level
- NTRB $6.40
- VATE $6.49
- Average True Range (ATR)
- NTRB 0.71
- VATE 0.43
- MACD
- NTRB -0.12
- VATE 0.05
- Stochastic Oscillator
- NTRB 33.23
- VATE 86.72
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.